Novel IKK inhibitors: β-carbolines

…, LC Dang, F Soucy, L Grenier, H Mazdiyasni… - Bioorganic & medicinal …, 2003 - Elsevier
Inhibitors of IκB kinase (IKK) have long been sought as specific regulators of NF-κB. A
screening effort of the endogenous IKK complex allowed us to identify 5-bromo-6-methoxy-β-…

Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans

…, H Lounsbury, P Chaturvedi, H Mazdiyasni… - … of Pharmacology and …, 2013 - ASPET
Targeted therapies that suppress B cell receptor (BCR) signaling have emerged as
promising agents in autoimmune disease and B cell malignancies. Bruton’s tyrosine kinase (Btk) …

Oral, ultra–long-lasting drug delivery: application toward malaria elimination goals

…, EA Wenger, S Mo, YAL Lee, H Mazdiyasni… - Science translational …, 2016 - science.org
Efforts at elimination of scourges, such as malaria, are limited by the logistic challenges of
reaching large rural populations and ensuring patient adherence to adequate pharmacologic …

[HTML][HTML] Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy

…, A Bershteyn, M Craig, SS Mo, H Mazdiyasni… - Nature …, 2018 - nature.com
The efficacy of antiretroviral therapy is significantly compromised by medication non-adherence.
Long-acting enteral systems that can ease the burden of daily adherence have not yet …

[HTML][HTML] Triggerable tough hydrogels for gastric resident dosage forms

…, L Booth, J Lin, YA Lucy Lee, H Mazdiyasni… - Nature …, 2017 - nature.com
Abstract Systems capable of residing for prolonged periods of time in the gastric cavity have
transformed our ability to diagnose and treat patients. Gastric resident systems for drug …

Asymmetric microbial reduction of prochiral 2, 2,-disubstituted cycloalkanediones

DW Brooks, H Mazdiyasni… - The Journal of organic …, 1987 - ACS Publications
Asymmetric microbial reduction of a series of 2, 2-disubstituted 1, 3-cycloalkanediones with
bakers’ yeast was examined as an example of an enzyme-catalyzed distinction of a …

Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kα

…, T St. Martin, M Labenski, H Mazdiyasni… - Journal of medicinal …, 2013 - ACS Publications
PI3Kα has been identified as an oncogene in human tumors. By use of rational drug design,
a targeted covalent inhibitor 3 (CNX-1351) was created that potently and specifically inhibits …

Temperature-responsive biometamaterials for gastrointestinal applications

…, AV Wahane, AM Hayward, H Mazdiyasni… - Science translational …, 2019 - science.org
We hypothesized that ingested warm fluids could act as triggers for biomedical devices. We
investigated heat dissipation throughout the upper gastrointestinal (GI) tract by administering …

A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment

…, M Castaneda, C Steiger, H Mazdiyasni… - Science translational …, 2019 - science.org
Multigram drug depot systems for extended drug release could transform our capacity to
effectively treat patients across a myriad of diseases. For example, tuberculosis (TB) requires …

Genotype-targeted local therapy of glioma

…, AR Kirtane, JJ Miller, H Mazdiyasni… - Proceedings of the …, 2018 - National Acad Sciences
Aggressive neurosurgical resection to achieve sustained local control is essential for
prolonging survival in patients with lower-grade glioma. However, progression in many of these …